(Q24323164)

English

Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis (English)

0 references

1 reference

Protein tyrosine phosphatase receptor type M

1 reference

stated in

GOA release 2020-03-11

response to drug

1 reference

stated in

GOA release 2020-03-11

1 reference

1 reference

Patrick A Singleton

1

0 references

Joe G N Garcia

series ordinal

2

0 references

Jonathan Moss

series ordinal

3

0 references

language of work or name

English

0 references

publication date

June 2008

0 references

published in

Molecular Cancer Therapeutics

0 references

volume

7

0 references

issue

6

0 references

page(s)

1669-79

0 references

Identifiers

DOI

10.1158/1535-7163.MCT-07-2217

0 references

PubMed publication ID

18566238

0 references

(Q24323164)

Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)